Results 31 to 40 of about 4,991,692 (213)

Altered gut microbiome composition in patients with Vogt-Koyanagi-Harada disease

open access: yesGut microbes, 2020
Background Vogt-Koyanagi-Harada (VKH) disease is a multisystemic autoimmune disorder characterized by granulomatous panuveitis. Gut microbiome has been considered to play a role in the pathogenesis of this disease but whether the alternation of gut ...
Zi Ye   +14 more
semanticscholar   +1 more source

Outcome of Nivolumab-Induced Vogt–Koyanagi–Harada Disease-Like Uveitis in a Patient Managed without Intravenous Methylprednisolone Therapy

open access: yesCase Reports in Ophthalmological Medicine, 2023
Background In recent years, immune checkpoint inhibitors (ICI) have been often used for several types of cancers. Immune-related adverse events (irAEs) are autoimmune responses caused by ICI.
Ryoji Nagai   +3 more
semanticscholar   +1 more source

Pigmented paravenous retinochoroidal atrophy associated with Vogt-Koyanagi-Harada disease: a case report

open access: yesBMC Ophthalmology, 2020
Background To describe a unique case of pigmented paravenous retinochoroidal atrophy that developed several years after Vogt-Koyanagi-Harada disease. Case presentation A 28-year-old woman presented with gradual vision loss in both eyes and nyctalopia for
Prithvi Ramtohul   +3 more
doaj   +1 more source

Vogt-Koyanagi-Harada disease: review of a rare autoimmune disease targeting antigens of melanocytes

open access: yesOrphanet Journal of Rare Diseases, 2016
Vogt-Koyanagi-Harada disease (VKHD) is a rare granulomatous inflammatory disease that affects pigmented structures, such as eye, inner ear, meninges, skin and hair.
M. Lavezzo   +7 more
semanticscholar   +1 more source

A COVID-19 perspective of Vogt–Koyanagi–Harada disease

open access: yesIndian Journal of Ophthalmology, 2023
Vogt–Koyanagi–Harada (VKH) disease, a bilateral granulomatous panuveitis associated with multisystem involvement, is a T-cell-mediated autoimmune disorder in which cytotoxic T-cell target melanocytes in genetically susceptible individuals.
Parthopratim Dutta Majumder   +3 more
doaj   +1 more source

Macular Abnormalities in Vogt-Koyanagi-Harada Disease

open access: yes, 2019
Purpose: To investigate the prevalence of macular abnormalities in Chinese Vogt-Koyanagi-Harada (VKH) patients. Methods: Clinical characteristics, therapeutic effectiveness and visual outcome were reviewed and analyzed.
Qingyun Zhou (391545)   +11 more
core   +2 more sources

Vogt-Koyanagi-Harada disease following influenza vaccination

open access: yesAmerican Journal of Ophthalmology Case Reports, 2022
Purpose: To report a case of Vogt–Koyanagi–Harada (VKH) disease following influenza vaccination. Observations: A 30-year-old Filipino male developed bilateral pain, redness, photophobia, floaters, headache and tinnitus 2 days after receiving the annual ...
Fahmeeda Murtaza   +3 more
doaj   +1 more source

Vogt-Koyanagi-Harada disease: a clinical case report [PDF]

open access: yes, 2023
Universitatea de Stat de Medicină şi Farmacie „Nicolae Testemiţanu”, Chişinău, Republica MoldovaIntroducere. Boala Vogt-Koyanagi-Harada (VKH) (sindromul uveomeningeal) se caracterizează prin uveita bilaterală și dereglări somatice generale precum ...
Magla, Tatiana   +3 more
core   +1 more source

Treatment and Prognosis of Vogt–Koyanagi–Harada Disease: Real-Life Experience in Long-Term Follow-Up

open access: yesJournal of Clinical Medicine, 2022
Background: Vogt–Koyanagi–Harada (VKH) disease is a form of uveitis that is rare in Western countries. The aim of this study was to report on the long-term real-life treatment and prognosis of VKH in Italy.
M. Accorinti   +5 more
semanticscholar   +1 more source

Aplicabilidade do critério diagnóstico revisado de 2001 em pacientes brasileiros com doença de Vogt-Koyanagi-Harada [PDF]

open access: yes, 2008
PURPOSE: To determine the applicability of the international revised diagnostic criteria for Vogt-Koyanagi-Harada disease. METHODS: Retrospective study.
Zajdenweber, Moysés Eduardo [UNIFESP]   +9 more
core   +2 more sources

Home - About - Disclaimer - Privacy